Ramiah Investment Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$546K Buy
4,246
+422
+11% +$49.4K 0.42% 34
2026
Q1
$460K Sell
3,824
-1,287
-25% -$149K 3.07% 11
2025
Q4
$538K Sell
5,111
-406
-7% -$38.1K 0.47% 36
2025
Q3
$463K Buy
5,517
+246
+5% +$20.3K 0.41% 45
2025
Q2
$417K Buy
5,271
+691
+15% +$54.9K 0.45% 47
2025
Q1
$411K Buy
4,580
+254
+6% +$23.7K 0.39% 42
2024
Q4
$430K Buy
4,326
+401
+10% +$41.3K 0.39% 49
2024
Q3
$446K Sell
3,925
-1,606
-29% -$191K 0.42% 48
2024
Q2
$685K Buy
+5,531
New +$712K 0.67% 41
2021
Q4
Sell
-9,374
Closed -$704K 87
2021
Q3
$704K Sell
9,374
-31
-0.3% -$2.36K 0.5% 50
2021
Q2
$731K Sell
9,405
-471
-5% -$35K 0.52% 45
2021
Q1
$726K Buy
+9,876
New +$728K 0.55% 45

Other funds holding MRK

Ramiah Investment Group's MRK Position: Q2 2026 in Review

Ramiah Investment Group increased its Merck (MRK) stake by 11% in Q2 2026, buying an estimated $49.4K and bringing the position to 4,246 shares worth $546K. The position accounts for 0.42% of the portfolio, ranked #34.

Ramiah Investment Group first reported a position in MRK in Q1 2021 and has held it in 12 quarters since. The position peaked at $731K in Q2 2021. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Ramiah Investment Group held 4,246 shares of Merck worth $546K as of Q2 2026.
  • Ramiah Investment Group bought 422 Merck shares in Q2 2026, an estimated $49.4K.
  • Merck made up 0.42% of Ramiah Investment Group's portfolio in Q2 2026, its #34 holding.
  • Ramiah Investment Group first reported a position in Merck in Q1 2021 and has held it in 12 quarters since.
  • Ramiah Investment Group's Merck position peaked at $731K in Q2 2021.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Ramiah Investment Group's 13F filing for Q2 2026, filed 16 Jul 2026.